Friday 6 November 2026 Export ZLAB’s income statement to Excel — free account

Zai Lab Limited Unsponsored ADR

Zai Lab Limited Unsponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $460.2 million, up 15.3% from fiscal 2024.

Revenue: −6.79%
EPS: −24.3%
Free cash flow: −95.5%
Total debt: +24.3%

Quarter to September 2026, against a year earlier

24.91 2.31 +10.22%

Follow ZLAB

Alert me

Market cap: $2.6B
P/E: 0.0×
Fwd P/E: −10.0×
Dividend yield: —
F-score: 4/9
Altman Z: −0.24
Beneish M: −2.35
Dividend safety: n/a

Overview

Zai Lab Limited Unsponsored ADR (ZLAB) Current ratio

Alert me on Current ratio

Zai Lab Limited Unsponsored ADR's current ratio at the end of the quarter to 30 September 2026 was 2.0×, down 0.4× from fiscal 2025 (2.4×). Over the past ten years it has ranged from 2.4× (fiscal 2025) to 19.1× (fiscal 2017) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 4.9× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ZLAB/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Zai Lab Limited Unsponsored ADR current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ZLAB/metrics/current-ratio">Zai Lab Limited Unsponsored ADR (ZLAB) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	2.4×	(30.20%)
FY2024	3.5×	(24.17%)
FY2023	4.6×	(42.45%)
FY2022	8.0×	3.33%
FY2021	7.8×	(37.27%)
FY2020	12.4×	97.78%
FY2019	6.3×	13.81%
FY2018	5.5×	(71.16%)
FY2017	19.1×	17.56%
FY2016	16.3×	384.21%

Period	Current ratio	Change
Sep 2026	2.0×	(4.46%)
Jun 2026	2.1×	(11.29%)
Mar 2026	2.4×	(1.85%)
Dec 2025	2.4×	(14.69%)
30 more quarters	Free account

Against its own ten years

Low 2.4× High 19.1×

Ten-year median 6.3×

Current reading's percentile 9

Company	Current ratio
MBX MBX Biosciences, Inc. compare	18.1×
PHVS Pharvaris N.V. compare	11.9×
CLDX Celldex Therapeutics, Inc. compare	11.8×
NAMS NewAmsterdam Pharma Company N.V. compare	11.8×
XNCR Xencor, Inc. compare	6.4×
ADMA ADMA Biologics Inc compare	6.0×
RXRX Recursion Pharmaceuticals, Inc. compare	5.0×
RCUS Arcus Biosciences, Inc. compare	3.3×
ZLAB Zai Lab Limited Unsponsored ADR	2.0×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Zai Lab Limited Unsponsored ADR (ZLAB) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on ZLAB

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on ZLAB

Stockrow Weekly